Euromonitor International’s Senior Research Analyst Alex Esposito interviews Cindy Bryant, Chief Business Officer at Demetrix about the world of cannabinoids beyond THC and CBD. Cindy explains Demetrix’s unique approach to using fermentation to produce cannabinoids and how this differs from predominant production methods. Alex and Cindy also delve into the potential of new cannabinoids other than THC and CBD, ways they can help consumers and how we’re only just beginning to understand the promise of cannabinoids for use in health and wellness. To learn more about Demetrix, see www.demetrixbio.com and dive into their unique approach to producing cannabinoids on their blog at www.demetrixbio.com/insights.